Michael Grosse is to manage the business of the laboratory and pharmaceutical supplier Sartorius from next summer.
The supervisory board appointed the manager as CEO on Friday with effect from July 1, 2025, the DAX group announced after the stock market closed in Göttingen. The current CEO Joachim Kreuzburg announced this July that he no longer wanted to extend his contract, which runs until November 2025. According to the company, the manager has been at the top of the company for more than 20 years. The Sartorius share rose by half a percent compared to the Xetra closing price on the Tradegate trading platform.
From 2020 to 2023, Grosse managed business at the process and packaging technology company Syntegon Technology, which was spun off from the Bosch Group in 2019.
GÖTTINGEN (dpa-AFX)
Selected leverage products on Sartorius
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Sartorius
The leverage must be between 2 and 20
Advertising
Image sources: T. Schneider / Shutterstock.com